Drug Eluting Temporary Spur Stent System vs Percutaneous Balloon Angioplasty for the Treatment of Critical Limb Ischemia

NANot yet recruitingINTERVENTIONAL
Enrollment

518

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

June 30, 2030

Study Completion Date

December 31, 2035

Conditions
Critical Limb Ischemia
Interventions
DEVICE

Drug Eluting Temporary Spur Stent System

The Spur Stent consists of a sirolimus coated stent and balloon that is retrievable after delivery of the sirolimus formulation.

DEVICE

Percutaneous Transluminal Balloon Angioplasty

A balloon catheter is inserted across a lesion and inflated to fracture and compress the plaque, creating a larger lumen and improved blood flow through the artery.

All Listed Sponsors
lead

ReFlow Medical, Inc.

INDUSTRY

NCT06122974 - Drug Eluting Temporary Spur Stent System vs Percutaneous Balloon Angioplasty for the Treatment of Critical Limb Ischemia | Biotech Hunter | Biotech Hunter